Skip to main content

DELAFIELD, Wis. (Stockpickr) -- As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Macrocure

  • Tuesday's Range: $3.19-$3.50
  • 52-Week Range: $2.60-$16.10
  • Tuesdays Volume: 40,000
  • Three-Month Average Volume: 206,955

Macrocure (MCUR) , a biotechnology company, focuses on developing, manufacturing and commercializing novel cell therapy products for the treatment of chronic and other hard-to-heal wounds in Israel. This stock is trading up 5.2% to $3.43 in Tuesday's trading session.

From a technical perspective, Macrocure is ripping higher here right above some near-term support at $3.10 with lighter-than-average volume. This stock has recently attempted to carve out a double bottom chart pattern, since this stock has found some buying interest over the last few weeks at $3 to $3.10 a share. Shares of Macrocure are now starting to spike higher above those support levels and it's beginning to flirt with its 20-day moving average of $3.42. Traders should now look for a continuation move to the upside in the short-term if this stock manages to clear Tuesday's intraday high of $3.59 and then more resistance at $4 with high volume.

Traders should now look for long-biased trades in Macrocure as long as it's trending above Tuesday's intraday low of $3.19 or above those recent double bottom support levels and then once it sustains a move or close above those breakout levels with volume that hits near or above 206,955 shares. If that move gets underway soon, then this stock will set up to re-test or possibly take out its next major overhead resistance level at $4.26. Any high-volume move above $4.26 will then give this stock a chance to make a run at its recent high of around $6 a share.

Exelixis

  • Tuesday's Range: $5.60-$6.07
  • 52-Week Range: $1.26-$6.81
  • Tuesday's Volume: 2.52 million
  • Three-Month Average Volume: 7.45 million

Exelixis (EXEL) - Get Exelixis, Inc. Report , a biopharmaceutical company, develops and sells small molecule therapies for the treatment of cancer in the U.S. This stock is trading up 3% to $5.83 in Tuesday's trading session.

TheStreet Recommends

From a technical perspective, Exelixis is spiking higher here right above some near-term support at $5.47 with lighter-than-average volume. This stock has been consolidating and trending sideways over the last three months, with shares moving between $4.56 on the downside and $6.80 on the upside. This move to the upside on Tuesday is now starting to push this stock within range of triggering a big breakout trade above the upper-end of its recent sideways trending chart pattern. That trade will trigger if this stock manages to take out some key overhead resistance levels at $6.25 to $6.77 and then above its 52-week high of $6.81 with high volume.

Traders should now look for long-biased trades in Exelixis as long as it's trending above some key near-term support levels at $5.47 to $5.46 and then once it sustains a move or close above those breakout levels with volume that registers near or above 7.45 million shares. If that breakout develops soon, then this stock will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $7.50 to $8.50 a share.

Prima Biomed

  • Tuesday's Range: $1.26-$1.35
  • 52-Week Range: $0.42-$6.48
  • Tuesday's Volume: 449,000
  • Three-Month Average Volume: 1.74 million

Prima Biomed (PBMD) researches, develops and commercializes medical biotechnology products in Australia. This stock is trading up 6.3% to $1.34 in Tuesday's trading session.

From a technical perspective, Prima Biomed is ripping higher here right off its 50-day moving average of $1.22 and back above its 20-day moving average of $1.28 with lighter-than-average volume. This stock recently formed a double bottom chart pattern, after shares found some buying interest at $1.15 to $1.14 a share. Following that bottom, shares of Prima Biomed have now started to spike higher above those support levels and it's quickly moving within range of triggering a near-term breakout trade. That breakout will trigger if this stock manages to take out some key near-term overhead resistance levels at $1.41 to $1.48 with high volume.

Traders should now look for long-biased trades in Prima Biomed as long as it's trending above its 50-day moving average $1.22 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.74 million shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $1.73 to $1.80. or even $2 a share.

Intrepid Potash

  • Tuesday's Range: $5.59-$5.84
  • 52-Week Range: $5.35-$15.69
  • Tuesday's Volume: 154,000
  • Three-Month Average Volume: 793,081

Intrepid Potash (IPI) - Get Intrepid Potash, Inc. Report engages in the extraction, production, and sale of potassium containing products in the U.S. This stock is trading up 1.4% to $5.77 in Tuesday's trading session.

From a technical perspective, Intrepid Potash is trending modestly higher here right above its recent 52-week low of $5.35 with lighter-than-average volume. This stock has been downtrending badly over the last six months, with shares falling sharply lower from its high of over $13 to its recent low of $5.35 a share. During that downtrend, shares of Intrepid Potash have been making mostly lower highs and lower lows, which is bearish technical price action.

That said, this bounce on Tuesday is now starting to push this stock within range of triggering a near-term breakout trade. That breakout will trigger if this stock manages to take out some near-term overhead resistance at $6.06 with high volume.

Traders should now look for long-biased trades in Intrepid Potash as long as it's trending above that new 52-week low of $5.35 and then once it sustains a move or close above $6.06 with volume that hits near or above 793,081 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 20-day moving average of $6.82 to $7.50, or even its 50-day moving average of $7.67 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.